This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:pathogenesis:th1spectrum [10.13.2018] – [Health and disease is a continuum] sallieq | home:pathogenesis:th1spectrum [02.10.2019] – [Metabolic syndrome] sallieq | ||
---|---|---|---|
Line 493: | Line 493: | ||
A corollary of this principle is that attempts to compare one patient' | A corollary of this principle is that attempts to compare one patient' | ||
+ | |||
+ | |||
+ | |||
+ | ==== Metabolic syndrome ==== | ||
+ | |||
+ | Impact of 25-hydroxyvitamin D, free and bioavailable fractions of vitamin D, and vitamin D binding protein levels on metabolic syndrome components | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | ===== Intestinal barrier ===== | ||
+ | |||
+ | Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, | ||
+ | |||
+ | The two major triggers of zonulin release that have been described so far are bacteria and gliadin. It is well described that many enteric pathogens are able to produce enterotoxins that affect the intestinal tight junction of the host. | ||